Brain health – A Decade of Impact and the Next Chapter (Report)

Brain health – A Decade of Impact and the Next Chapter MS Brain Health has played a pivotal role in advancing a paradigm shift in the management of MS. After a decade under the auspices of Oxford Health Policy Forum CIC and it’s HealthScience Communication partner Oxford PharmaGenesis, the initiative is changing hands. The next…

Read More

Brain health – A Decade of Impact and the Next Chapter

MS Brain Health has played a pivotal role in advancing a paradigm shift in the management of MS. After a decade under the auspices of Oxford Health Policy Forum CIC and it’s HealthScience Communication partner Oxford PharmaGenesis, the initiative is changing hands. The next exciting phase requires expertise that is beyond the remit of the…

Read More

Brain health – time matters 2024: MS, NMOSD, MOGAD and related conditions (Report)

Brain health – time matters 2024: MS, NMOSD, MOGAD and related conditions Since our first publication in 2015, care and treatment in neuroimmune conditions have hugely advanced. This new report delves into these advancements and addresses the ongoing needs of those living with these lifelong conditions. MS, NMOSD, and MOGAD are related, chronic, incurable diseases…

Read More

Schizophrenia: Time to Commit to Policy Change 2024 (Report)

Schizophrenia: Time to Commit to Policy Change 2024 Schizophrenia is recognised as one of the most complex and profound mental health conditions, steeped in both myth and reality. Efforts needs to be multifaceted, including policy development, treatment guidance and scientific innovation, with all stakeholders working together to ensure meaningful progress. This report delves into the…

Read More

Schizophrenia – Time to Commit to Policy Change 2024

With this report we hope to build a collaborative platform to share insights and build valuable connections for mental health policy in schizophrenia. It has been developed in collaboration with experts: Silvana Galderisi, Davi Kaur, Peter Kéri, Belinda Lennox, Stephen Marder, David McDaid, Tina Matthews Hayes, Sabine MULLERSabine, Fiona Nolan, Merete Nordentoft, Pavalkis Dainius, John…

Read More

MS Brain Health highly commended in the 2023 PRIME Award for Sustained Excellence

The PRIME Awards recognize and celebrates excellence within healthcare communications and the Australian pharmaceutical and life sciences industry. The awards ceremony took place in Sydney, Australia, on Thursday 9 November 2023. The shortlisting of MS Brain Health for an award recognizes the impact of the policy recommendations and resources for people living with multiple sclerosis…

Read More